AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 41 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $10,525,000 | +186.4% | 747,500 | +139.2% | 1.12% | +67.1% |
Q4 2017 | $3,675,000 | -17.1% | 312,500 | 0.0% | 0.67% | -33.4% |
Q3 2017 | $4,434,000 | -40.0% | 312,500 | -40.5% | 1.01% | -42.6% |
Q2 2017 | $7,387,000 | -49.6% | 525,000 | -40.2% | 1.76% | -45.1% |
Q1 2017 | $14,650,000 | +1.1% | 877,753 | 0.0% | 3.20% | -42.9% |
Q4 2016 | $14,492,000 | +23.6% | 877,753 | 0.0% | 5.61% | +6.7% |
Q3 2016 | $11,727,000 | +101.8% | 877,753 | 0.0% | 5.26% | +2.0% |
Q2 2016 | $5,811,000 | -19.7% | 877,753 | +7.0% | 5.15% | -27.2% |
Q1 2016 | $7,233,000 | -28.4% | 820,015 | +1.3% | 7.08% | -18.8% |
Q4 2015 | $10,101,000 | – | 809,415 | – | 8.72% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,265,880 | $6,639,000 | 0.60% |
Ghost Tree Capital, LLC | 500,000 | $1,465,000 | 0.31% |
Baker Brothers Advisors | 10,934,154 | $32,037,000 | 0.21% |
MYDA Advisors LLC | 100,000 | $293,000 | 0.16% |
Prosight Management, LP | 56,650 | $166,000 | 0.09% |
Telemetry Investments, L.L.C. | 45,470 | $133,000 | 0.06% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 480,108 | $1,407,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 186,443 | $546,000 | 0.03% |
Kalos Management, Inc. | 16,650 | $46,000 | 0.02% |
Dynamic Technology Lab Private Ltd | 46,376 | $136,000 | 0.02% |